Cargando…

Molecular markers to assess short-term disease local recurrence in nasopharyngeal carcinoma

An important challenge in nasopharyngeal carcinoma (NPC) research is to develop effective predictors of tumor recurrence following treatment to determine whether immediate adjuvant therapy is necessary. We retrospectively analyzed archived specimens collected from 45 patients with paired samples of...

Descripción completa

Detalles Bibliográficos
Autores principales:	XU, TAO, SU, BOJIN, WANG, CHUNHUA, WANG, SUMEI, HUANG, HECHENG, PAN, YUNBAO, WANG, DONGHUI, WEI, WEIHONG, CLARET, FRANÇOIS X., YANG, HUILING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324483/ https://www.ncbi.nlm.nih.gov/pubmed/25607111 http://dx.doi.org/10.3892/or.2015.3739

Ejemplares similares

Curcumin analogue T83 exhibits potent antitumor activity and induces radiosensitivity through inactivation of Jab1 in nasopharyngeal carcinoma
por: Pan, Yunbao, et al.
Publicado: (2013)

Hsa-miR-24-3p Increases Nasopharyngeal Carcinoma Radiosensitivity by Targeting Both the 3’UTR and 5’UTR of Jab1/CSN5
por: Wang, Sumei, et al.
Publicado: (2016)

Suppression of Jab1/CSN5 induces radiation- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways
por: Pan, Yunbao, et al.
Publicado: (2012)

Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
por: Pan, Yunbao, et al.
Publicado: (2013)

Correction: Stat3 inhibitor stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma
por: Pan, Yunbao, et al.
Publicado: (2020)

Stat3 Contributes to Cancer Progression by Regulating Jab1/Csn5 Expression
por: Pan, Yunbao, et al.
Publicado: (2016)

MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma
por: Wang, Sumei, et al.
Publicado: (2019)

hsa-miR-24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c-Myc/epithelial-mesenchymal transition axis
por: Su, Bojin, et al.
Publicado: (2018)

Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer
por: Liu, Guohong, et al.
Publicado: (2018)

YAP1 Promotes Tumor Invasion and Metastasis in Nasopharyngeal Carcinoma with Hepatitis B Virus Infection
por: Huang, Zeli, et al.
Publicado: (2020)

Constitutive control of AKT-1 gene expression by JUNB / CJUN in ALK+ anaplastic large cell lymphoma: a novel crosstalk mechanism
por: Atsaves, Vassilios, et al.
Publicado: (2015)

Prognostic Value of Clinical Biochemistry-Based Indexes in Nasopharyngeal Carcinoma
por: Zeng, Xiaojiao, et al.
Publicado: (2020)

Treatment of Recurrent Nasopharyngeal Carcinoma: A Sequential Challenge
por: Peng, Zhouying, et al.
Publicado: (2022)

Retreatment in locally recurrent nasopharyngeal carcinoma: Current status and perspectives
por: Poh, Sharon Shuxian, et al.
Publicado: (2021)

The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications
por: Yang, Liu, et al.
Publicado: (2021)

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
por: Tian, Y-M, et al.
Publicado: (2014)

Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma
por: Wang, Liping, et al.
Publicado: (2022)

Development and validation of immune inflammation–based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma
por: Zeng, Xiaojiao, et al.
Publicado: (2020)

Preliminary Efficacy Report and Prognosis Analysis of Endoscopic Endonasal Nasopharyngectomy for Recurrent Nasopharyngeal Carcinoma
por: Peng, Zhouying, et al.
Publicado: (2021)

Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling
por: Wang, Liping, et al.
Publicado: (2023)

Immune Microenvironment Change and Involvement of Circular RNAs in TIL Cells of Recurrent Nasopharyngeal Carcinoma
por: Wang, Yumin, et al.
Publicado: (2021)

Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma
por: Zong, Jing-Feng, et al.
Publicado: (2021)

CT-guided (125)I brachytherapy for locally recurrent nasopharyngeal carcinoma
por: Yan, Huzheng, et al.
Publicado: (2017)

Long-Term Outcomes of Three-Dimensional High-Dose-Rate Brachytherapy for Locally Recurrent Early T-Stage Nasopharyngeal Carcinoma
por: Lin, Yanzhu, et al.
Publicado: (2019)

Salvage Endoscopic Skull Base Surgery: Another Treatment Option After Immunotherapy for Recurrent Nasopharyngeal Carcinoma
por: Peng, Zhouying, et al.
Publicado: (2022)

Effectiveness and Toxicities of Intensity-Modulated Radiotherapy for Patients with Locally Recurrent Nasopharyngeal Carcinoma
por: Chen, Hai-yan, et al.
Publicado: (2013)

Dosimetric comparison and observation of three-dimensional conformal radiotherapy for recurrent nasopharyngeal carcinoma
por: Pan, Rongqiang, et al.
Publicado: (2017)

Comparing the Effectiveness of Endoscopic Surgeries With Intensity-Modulated Radiotherapy for Recurrent rT3 and rT4 Nasopharyngeal Carcinoma: A Meta-Analysis
por: Peng, Zhouying, et al.
Publicado: (2021)

Unraveling the patterns and pathways of local recurrence of nasopharyngeal carcinoma: evidence for individualized clinical target volume delineation
por: Ou, Xiaomin, et al.
Publicado: (2023)

Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
por: Chia, Whay-Kuang, et al.
Publicado: (2014)

Prognostic markers compared to CD3+TIL in locally advanced nasopharyngeal carcinoma
por: Al-Rajhi, Nasser, et al.
Publicado: (2021)

A Short-Term Efficacy of Anlotinib in the Treatment of Refractory Nasopharyngeal Inverted Papilloma: A Case Report
por: Yang, Pan, et al.
Publicado: (2021)

Effects of Surgery Combined with Chemoradiotherapy on Short- and Long-Term Outcomes of Early-Stage Nasopharyngeal Carcinoma
por: Weng, Jing-Jin, et al.
Publicado: (2020)

The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma
por: Guan, Ying, et al.
Publicado: (2015)

Impact of primary tumor volume and location on the prognosis of patients with locally recurrent nasopharyngeal carcinoma
por: Tian, Yun-Ming, et al.
Publicado: (2015)

With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case–control study
por: Liu, Li-Ting, et al.
Publicado: (2016)

Radiomic Nomogram: Pretreatment Evaluation of Local Recurrence in Nasopharyngeal Carcinoma based on MR Imaging
por: Zhang, Lu, et al.
Publicado: (2019)

The Role of Circulating Tumor Cells in the Prognosis of Local Recurrence and Local Residual Nasopharyngeal Carcinoma Undergoing Endoscopic Resection
por: Tang, Liang, et al.
Publicado: (2022)

Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach
por: Meng, Huiling, et al.
Publicado: (2017)

Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
por: Liu, Guohong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vlfhdtu3h19ij6ff3lp89cvf52